摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Cortistatin L | 944804-65-3

中文名称
——
中文别名
——
英文名称
Cortistatin L
英文别名
(1S,2R,5S,6R,13S,14S,16R)-14-(dimethylamino)-5-isoquinolin-7-yl-6-methyl-19-oxapentacyclo[14.2.1.01,9.02,6.011,16]nonadeca-9,11-dien-13-ol
Cortistatin L化学式
CAS
944804-65-3
化学式
C30H36N2O2
mdl
——
分子量
456.628
InChiKey
ZIMMLBWISNFYGV-KDHYMLRHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    34
  • 可旋转键数:
    2
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    45.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • SYNTHESIS OF (+) CORTISTATIN A AND RELATED COMPOUNDS
    申请人:Shenvi Ryan A.
    公开号:US20110060140A1
    公开(公告)日:2011-03-10
    An in vitro synthesis of (+) cortistatin A from readily available precursors is disclosed, as are the syntheses of related 17-aryl substituted compounds, the 17-aryl substituted compounds themselves and novel compounds useful in their preparation.
    本文披露了一种从易得前体体外合成(+) cortistatin A的方法,以及相关的17-芳基取代化合物的合成,17-芳基取代化合物本身以及其制备中有用的新化合物。
  • CORTISTATIN ANALOGUES AND SYNTHESES THEREOF
    申请人:Flyer Alec Nathanson
    公开号:US20110190323A1
    公开(公告)日:2011-08-04
    The present invention relates to analogs of cortistatin A, J, K, and L, having the general formula: I and salts thereof, wherein R 1 , R 2 , R 3 , R 4 , n, and m are as defined herein; processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; methods for treating a proliferative disease; methods for treating a disease associated with aberrant angiogenesis; methods for inhibiting angiogenesis; and processes for preparing cortistatin A, J, K, and L, and analogs thereof.
  • CORTISTATIN ANALOGUES AND SYNTHESES THEROF
    申请人:President and Fellows of Harvard College
    公开号:US20150111921A1
    公开(公告)日:2015-04-23
    The present invention relates to analogs of cortistatin A, J, K, and L, having the general formula: I and salts thereof, wherein R 1 , R 2 , R 3 , R 4 , n, and m are as defined herein; processes for preparing such compounds and intermediates thereto; pharmaceutical compositions comprising such compounds; methods for treating a proliferative disease; methods for treating a disease associated with aberrant angiogenesis; methods for inhibiting angiogenesis; and processes for preparing cortistatin A, J, K, and L, and analogs thereof.
  • US8642766B2
    申请人:——
    公开号:US8642766B2
    公开(公告)日:2014-02-04
  • US9127019B2
    申请人:——
    公开号:US9127019B2
    公开(公告)日:2015-09-08
查看更多